ConductScience.org, home

Paper8093722

Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.

Ueki S and 8 others. J Pharmacol Exp Ther, 1993. Cited by 51 papers, by iCite.

Cite this record

ConductScience Library. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats. Papers, record 8093722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8093722

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1993
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
2.61
iCite
Revised in PubMed
2018-11-30
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ueki SS
2Seiki MM
3Yoneta TT
4Aita HH
5Chaki KK
6Hori YY
7Morita HH
8Tagashira EE
9Itoh ZZ

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal MotilityMajor topic
NizatidineMajor topic
Animals
Cholinesterase Inhibitors
Cimetidine
Digestive System
Digestive System Physiological Phenomena
Dogs
Dose-Response Relationship, Drug
Famotidine
Fasting
Gastric Acid
Gastric Emptying
Histamine H2 Antagonists
Humans
Male
Motor Activity
Pylorus
Rats
Rats, Sprague-Dawley

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
42268283Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment.J Parkinsons Dis2026https://conductscience.org/library/papers/42268283PubMed
34390398Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update.Support Care Cancer2021https://conductscience.org/library/papers/34390398PubMed
23556039A study of the effects of saliva stimulation by nizatidine on dry mouth symptoms of primary biliary cirrhosis.World J Hepatol2013https://conductscience.org/library/papers/23556039PubMed
23403922The effects of huperzine A on gastrointestinal acetylcholinesterase activity and motility after single and multiple dosing in mice.Exp Ther Med2013https://conductscience.org/library/papers/23403922PubMed
22216022Effects of proton pump inhibitors and h(2) receptor antagonists on the ileum motility.Gastroenterol Res Pract2011https://conductscience.org/library/papers/22216022PubMed
19115465Gastroparesis: current diagnostic challenges and management considerations.World J Gastroenterol2009https://conductscience.org/library/papers/19115465PubMed
18979143Does the use of nizatidine, as a pro-kinetic agent, improve gastric emptying in patients post-oesophagectomy?J Gastrointest Surg2009https://conductscience.org/library/papers/18979143PubMed
16416222
Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
Dig Dis Sci2006https://conductscience.org/library/papers/16416222PubMed
15139487Nizatidine and cisapride increase salivary secretion in rats.Dig Dis Sci2004https://conductscience.org/library/papers/15139487PubMed
12645792Effects of rabeprazole sodium on gastric emptying, electrogastrography, and fullness.Dig Dis Sci2003https://conductscience.org/library/papers/12645792PubMed
11819669Stimulation by nizatidine, a histamine H(2)-receptor antagonist, of duodenal HCO(3)(-)secretion in rats:relation to anti-cholinesterase activity.World J Gastroenterol2000https://conductscience.org/library/papers/11819669PubMed
11819299A review of reflux esophagitis around the world.World J Gastroenterol1998https://conductscience.org/library/papers/11819299PubMed
9539643Ranitidine and nizatidine stimulate antral smooth muscle contractility via excitatory cholinergic mechanisms.Dig Dis Sci1998https://conductscience.org/library/papers/9539643PubMed
8617117Omeprazole causes delay in gastric emptying of digestible meals.Dig Dis Sci1996https://conductscience.org/library/papers/8617117PubMed
7712661Pharmacokinetic considerations in gastrointestinal motor disorders.Clin Pharmacokinet1995https://conductscience.org/library/papers/7712661PubMed
7555463Nizatidine accelerates gastric emptying of a solid meal in rats.Dig Dis Sci1995https://conductscience.org/library/papers/7555463PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8093722

GET https://conductscience.org/api/papers/v1/8093722/authors